Nexlizet 180 MG / 10 MG Oral Tablet
- RxCUI
- 2283236
- RxNorm name
- Nexlizet 180 MG / 10 MG Oral Tablet
- Display name
- Nexlizet 180 MG / 10 MG Oral Tablet
- Full name
- Nexlizet 180 MG / 10 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:55
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nexlizet | BEMPEDOIC ACID AND EZETIMIBE | Esperion Therapeutics, Inc. | 3fa2108c-0300-47b8-9d34-f762af7c93c6 | 2026-06-25 | Warnings, Adverse reactions | 2283236 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3fa2108c-0300-47b8-9d34-f762af7c93c6 | Nexlizet 180 MG / 10 MG Oral Tablet | PSN | 22 | These highlights do not include all the information needed to use NEXLIZET ® safely and effectively. See full prescribing information for NEXLIZET. NEXLIZET (bempedoic acid and ezetimibe) tablets, for oral use Initial U.S. Approval: 2020 | 20260115 |
| 3fa2108c-0300-47b8-9d34-f762af7c93c6 | bempedoic acid 180 MG / ezetimibe 10 MG Oral Tablet [Nexlizet] | SBD | 22 | These highlights do not include all the information needed to use NEXLIZET ® safely and effectively. See full prescribing information for NEXLIZET. NEXLIZET (bempedoic acid and ezetimibe) tablets, for oral use Initial U.S. Approval: 2020 | 20260115 |
| 3fa2108c-0300-47b8-9d34-f762af7c93c6 | Nexlizet (bempedoic acid 180 MG / ezetimibe 10 MG) Oral Tablet | SY | 22 | These highlights do not include all the information needed to use NEXLIZET ® safely and effectively. See full prescribing information for NEXLIZET. NEXLIZET (bempedoic acid and ezetimibe) tablets, for oral use Initial U.S. Approval: 2020 | 20260115 |